Compare AMRX & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | GTX |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | N/A | N/A |
| Metric | AMRX | GTX |
|---|---|---|
| Price | $13.58 | $18.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $13.25 | ★ $20.00 |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 02-27-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | N/A | ★ 55.30 |
| EPS | 0.02 | ★ 1.57 |
| Revenue | $2,934,959,000.00 | ★ $3,537,000,000.00 |
| Revenue This Year | $9.99 | $3.71 |
| Revenue Next Year | $6.48 | $3.11 |
| P/E Ratio | $843.33 | ★ $11.48 |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $6.69 | $7.02 |
| 52 Week High | $13.75 | $19.28 |
| Indicator | AMRX | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.18 | 51.96 |
| Support Level | $13.30 | $17.87 |
| Resistance Level | $13.75 | $18.72 |
| Average True Range (ATR) | 0.33 | 0.54 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 84.86 | 27.51 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.